Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?

This publication has 18 references indexed in Scilit:

• Personal review: is profound acid inhibition safe?
  Alimentary Pharmacology & Therapeutics, 2000
• ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis
  Gastroenterology, 1999
• Serum gastrin and chromogranin A during medium‐ and long‐term acid suppressive therapy: a case‐control study
  Alimentary Pharmacology & Therapeutics, 1999
• Safety Profile of Lansoprazole
  Drug Safety, 1999
• Gastric morphology during long-term omeprazole therapy
  Gastroenterology, 1998
• The Risk of Gastric Carcinoma and Carcinoid Tumours in Patients with Pernicious Anaemia: A Prospective Follow-Up Study
  Scandinavian Journal of Gastroenterology, 1998
• Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
  Gut, 1994
• Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine
  Scandinavian Journal of Gastroenterology, 1991
• Gastric Argyrophil Carcinoidosis in Patients with Zollinger-Ellison Syndrome Due to Type 1 Multiple Endocrine Neoplasia
  The American Journal of Surgical Pathology, 1990
• Pharmacology and Toxicology of Omeprazole with Special Reference to the Effects on the Gastric Mucosa
  Scandinavian Journal of Gastroenterology, 1986